Non Invasive Prenatal Testing (NIPT)

Back to Tests

Non Invasive Prenatal Testing - CHROME (NIPT-CHROME)

Cell-free DNA fragments (cfDNA) are short fragments of DNA, which can be found circulating in the blood. During pregnancy, cfDNA fragments originating from both the mother and the fetus are present in maternal circulation.

The test requires taking a small maternal blood sample. This is then analysed with our proprietary genetic sequencing technology and bioinformatics to screen for any chromosomal abnormality in the fetus.

The technology behind CHROME allows for highly accurate results with detection rates of over 99.5% for the three most common trisomy conditions present at birth (Down Syndrome, Edwards Syndrome and Patau Syndrome).

Download Brochure

CHROME Non Invasive Prenatal Testing process and results

Types:

CHROME Focus

Testing of 5 Common chromosomal aneuploidies – chr 13, 18, 21, X & Y

CHROME Comprehensive

Aneuploidy testing for all chromosomes

CHROME Plus

Aneuploidy testing of 23 chromosomes + 6 microdeletions:

  • DiGeorge (22q11.2)
  • Angelman (15q11.2)
  • Prader-willi (15q11.2)
  • Cri-du-chat (5p)
  • Wolf-Hirschhorn syndrome (4p)
  • 1p36 deletion
TAT: 7–10 Working Days
TEST REQUISITION FORM (TRF)

Certified & Accredited

Accreditations

CAP Accreditation

9007683

CLIA Accreditation

34D2205781